Lawsuits on mRNA technology show profit-driven struggle for control over vital scientific discoveries
Introduction “Indeed, it was not an overnight [the mRNA vaccines], but decades of overnight and hard work which led to us—me, Drew Weissman [Colleague and close collaborator] and Pieter Cullis—to do this, and I have to say, thousands of other scientists. Science is a group activity and there is not ‘I,’ but ‘We, we, we.’ And even those people who came well before us and they are not with us anymore, we learned from them through the decades.”—Senior Vice President of BioNTech in Germany, Dr. Katalin Karikó“The number of applications for mRNA and siRNA [silencing RNA] that various companies are exploiting … we’ve only touched the surface of this … It’s completely revolutionary. We are moving into an era of personalized therapeutics.”—Dr. Pieter Cullis, Professor of Biochemistry and Molecula...